Gastrointestinal cancer studies in the human to nude mouse heterotransplant system.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 321290)

Published in Gastroenterology on May 01, 1977

Authors

M Schmidt, E E Deschner, H T Thaler, L Clements, R A Good

Articles by these authors

(truncated to the top 100)

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77

In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26

Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest (1967) 9.01

Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med (1981) 6.82

Contribution of anthropogenic and natural sources to atmospheric methane variability. Nature (2006) 5.66

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63

Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52

Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med (1976) 5.50

Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med (2001) 4.73

Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64

Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41

Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A (1981) 4.38

Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22

Mechanism of met oncogene activation. Cell (1986) 4.20

The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07

Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97

The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res (2000) 3.83

Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69

Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med (1968) 3.54

Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26

Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg (1995) 3.24

Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12

Distribution of brain metastases. Arch Neurol (1988) 3.11

Clinical classification of cardiac deaths. Circulation (1982) 2.93

GroE facilitates refolding of citrate synthase by suppressing aggregation. Biochemistry (1991) 2.92

Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med (1980) 2.89

How practical are recommendations for dietary control in phenylketonuria? Lancet (2002) 2.82

Protein conformational relaxation and ligand migration in myoglobin: a nanosecond to millisecond molecular movie from time-resolved Laue X-ray diffraction. Biochemistry (2001) 2.73

Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst (1995) 2.70

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology (2001) 2.69

Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. Int Arch Allergy Appl Immunol (1967) 2.64

The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53

C2 deficiency. Development of lupus erythematosus. J Clin Invest (1973) 2.52

A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50

A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females. Lancet (1967) 2.47

Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res (1994) 2.46

Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45

Enzymes for RNA sequence analysis. Preparation and specificity of exoplasmodial ribonucleases I and II from Physarum polycephalum. J Biol Chem (1978) 2.44

An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc Natl Acad Sci U S A (1992) 2.43

Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41

Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer (2002) 2.38

The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38

Effects of protein insufficiency on immune responsiveness. Am J Clin Nutr (1974) 2.37

Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes. J Exp Med (1969) 2.36

Chemical suppression of adaptive immunity. Adv Immunol (1967) 2.35

Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A (1981) 2.33

NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol (1993) 2.32

Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer (1971) 2.31

Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med (1968) 2.31

The process of metastasisation for breast cancer. Eur J Cancer (2003) 2.30

Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol (1996) 2.30

T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25

The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol (1999) 2.22

Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med (1993) 2.22

Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16

Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest (1976) 2.15

Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology (1990) 2.13

Improved tests for the evaluation of neutrophil function in human disease. J Lab Clin Med (1968) 2.11

A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11

Early infant mortality in West Germany before and after Chernobyl. Lancet (1989) 2.07

Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol (1969) 2.06

The yeast cell wall and septum as paradigms of cell growth and morphogenesis. J Biol Chem (2001) 2.05

Kaposi's sarcoma: a review and recent developments. CA Cancer J Clin (1981) 2.05

Facilitating networks of information. Proc AMIA Symp (2000) 2.05

Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A (1999) 2.04

Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04

Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A (1985) 2.04

A PC program for estimating organ dose and effective dose values in computed tomography. Eur Radiol (1999) 2.03

Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A (1985) 2.03

Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany. Vox Sang (2011) 2.02

Phytohaemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature (1967) 1.99

Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage. J Exp Med (1972) 1.99

Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood (1983) 1.98

Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98

Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97

The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest (1966) 1.96

Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med (1980) 1.94

The memorial symptom assessment scale short form (MSAS-SF). Cancer (2000) 1.94

Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) (1970) 1.94

New gentamicin-resistance and lacZ promoter-probe cassettes suitable for insertion mutagenesis and generation of transcriptional fusions. Gene (1995) 1.94

Glomerular localization and transport of aggregated proteins in mice. Lab Invest (1967) 1.94

Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A (1969) 1.92

Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. J Exp Med (1977) 1.91

Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol (1976) 1.87

The mycosubtilin synthetase of Bacillus subtilis ATCC6633: a multifunctional hybrid between a peptide synthetase, an amino transferase, and a fatty acid synthase. Proc Natl Acad Sci U S A (1999) 1.87

The measurement of symptoms in children with cancer. J Pain Symptom Manage (2000) 1.85

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83

Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83

Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82

Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. Biopolymers (2000) 1.82

Pneumocystis carinii infection. Medicine (Baltimore) (1973) 1.79

Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate. J Allergy Clin Immunol (1998) 1.77

Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation. Cell Immunol (1977) 1.76

Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med (1967) 1.76

Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med (1975) 1.75

Absence of enhancing antibody in cell mediated immunity to tumour heterografts in protein deficient rats. Nature (1971) 1.74

N.B.T. test stimulated. Lancet (1970) 1.73

B and T lymphocytes in primary immunodeficiency disease in man. J Clin Invest (1973) 1.72